Dr. Marc Steben

Dr. Marc Steben

Board of Directors

(he/him/his)

As Co-President of the organization, Dr. Steben is a family practitioner and a sexual health consultant and his research focuses mostly on chronic genital disease including HPV. He is a professor, the Social and Preventive Medicine department of the School of public health at Université de Montréal. He is a sexual health expert. He is a consultant at Family Medicine Group 1851 where is clinical practice is devoted to multidisciplinary approach to sexual health.

He is a member of the Canadian STI guidelines expert group. He has chaired the 26th International papillomavirus society meeting as well as the first Public health workshop and Clinical workshop in July 2010. He is Chair of the Canadian network on HPV prevention International Centre for Infectious Diseases. He is on the board of the International Society for the Study of Vulvo-vaginal Disease, International papillomavirus society and American STD association. He is a founding member of IUSTI Canada branch of IUSTI North America.

Publications

A Review of the Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: 10 Years of Clinical Experience in Canada

Marc Steben, MD; 1 Mattea Tan Thompson, PhD; 2 Caroline Rodier, MPH; 2 Nathalie Mallette, BScA; 2
Voica Racovitan, BPharm; 2 Fern DeAngelis, MSc; 2 Melissa Stutz, BSc; 3
Emmanouil Rampakakis, PhD 3
1 Sexually Transmitted Infections Unit, Institut national de santé publique du Québec, Montréal, QC
2 Merck Canada Inc., Kirkland, QC
3 JSS Medical Research, Saint-Laurent, QC

A National Survey of Canadian Physicians on HPV-JOGC: Knowledge, Barriers, and preventative practices

Marc Steben, MD; 1 Nancy Durand, MD; 2,3 Juliet Guichon, SJD; 4 Zoë R. Greenwald, MSc; 5 Susan Mc Faul, MD; 6 Jennifer Blake, MD 7
1 STI Unit, Institut national de sante publique du Quebec, Montreal, QC
2 Sunnybrook Health Sciences Centre, Department of Obstetrics and Gynaecology, Toronto, ON
3 Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON
4 Department of Community Health Sciences, University of Calgary, Calgary, AB
5 Department of Epidemiology, Clinique medicale l’Actuel, Montreal, QC
6 Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON
7 Society of Obstetricians and Gynaecologists of Canada, Ottawa, ON

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

Suzanne M. Garland, M.D., Mauricio Hernandez-Avila, M.D., Cosette M. Wheeler, Ph.D., Gonzalo Perez, M.D., Diane M. Harper, M.D., M.P.H., Sepp Leodolter, M.D., Grace W.K. Tang, M.D., Daron G. Ferris, M.D., Marc Steben, M.D., Janine Bryan, Ph.D., Frank J. Taddeo, Ph.D., Radha Railkar, Ph.D., Mark T. Esser, Ph.D., Heather L. Sings, Ph.D., Micki Nelson, B.S., John Boslego, M.D., Carlos Sattler, M.D., Eliav Barr, M.D., and Laura A. Koutsky, Ph.D., for the Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators

A National Survey of Canadian Adults on HPV: Knowledge, Attitudes, and Barriers to the HPV Vaccine

Marc Steben, MD; 1 Nancy Durand, MD; 2,3 Juliet Guichon, SJD; 4 Zoë R. Greenwald, MSc; 5 Susan Mc Faul, MD; 6 Jennifer Blake, MD 7
1 STI Unit, Institut national de sante publique du Quebec, Montreal, QC
2 Sunnybrook Health Sciences Centre, Department of Obstetrics and Gynaecology, Toronto, ON
3 Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON
4 Department of Community Health Sciences, University of Calgary, Calgary, AB
5 Department of Epidemiology, Clinique medicale l’Actuel, Montreal, QC
6 Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON
7 Society of Obstetricians and Gynaecologists of Canada, Ottawa, ON

IPVS Policy Statement addressing the burden of HPV disease for Indigenous peoples

Beverley Lawton a, Margaret Heffernan b, George Wurtak c, Marc Steben d,e, Pema Lhaki f, Fiona Cram g, Magaly Blas h, Merilyn Hibma i, Anna Adcock j, Kendall Stevenson j, Lisa Whop k, Julia Brotherton l,m, Suzanne M. Garland n,∗∗
a Centre for Women’s Health Research Centre for Women’s Health Research, Te Tātai Hauora O Hine Faculty of Health, Te Wāhanga Tātai Hauora Victoria University of Wellington, Te Whare Wānanga o te Ūpoko o te Ika a Māui, PO Box 600, Wellington, 6140, New Zealand
b School of Management, RMIT Business Level 8, Bldg 80, Rm 83, 445 Swanston Street, GPO Box 2476V, Melbourne, 3001, Victoria, Australia
c Consortium for Infectious Disease Control Director, Canadian HPV Prevention Network Co-Chair, International Indigenous HPV Alliance International Centre for Infectious Diseases Suite 1RC029, Richardson College for the Environment and Science Complex In the University of Winnipeg, 599 Portage Avenue, Winnipeg, Manitoba, Canada
d Médecin de Famille Groupe de médecine familiale La Cité du Parc Lafontaine, 1851 Sherbrooke est suite, 1110, Montréal, Canada e Président Réseau Canadien de Prévention du VPH/ Chair Canadian Network for HPV Prevention Président, Communications Action Santé inc, Canada
f NFCC, Lalitpur, Nepal
g Katoa Ltd, PO Box 105611, Auckland City, Auckland, 1143, Aotearoa, New Zealand
h Universidad Peruana Cayetano Heredia, UPCH, Facultad de Salud Pública y Administración, Peru
i Department of Pathology Dunedin School of Medicine, University of Otago, 58 Hanover St P O Box 913, Dunedin Central, 5054, New Zealand
j Te Tātai Hauora o Hine the Centre for Women’s Health Research at Victoria University of Wellington, New Zealand
k NHMRC, Early Career Research Fellow Wellbeing and Preventable Chronic Disease Division, Australia
l , VCS Population Health B Med (Hons), MPH (Hons), Grad Dip App Epi, FAFPHM, PhD, GAICDHonorary Principal Fellow Melbourne School of Population and Global Health University of Melbourne, Australia
m VCS Foundation Ltd, Level 6, 176 Wellington Parade, East Melbourne VIC, 3002, Australia
n Department of Obstetrics and Gynaecology, University of Melbourne, Director Centre Women’s Infectious Diseases Research Honorary Research Fellow, Infection & Immunity, Murdoch Children’s Research Institute, Parkville VIC, 3052, Australia

What do Key Stakeholders Think About HIV Self-Testing in Canada? Results from a Cross-Sectional Survey

N. Pant Pai • M. Smallwood • D. Gulati • N. Lapczak • A. Musten 3• C. Gaydos 4• C. Johnston 5• M. Steben • T. Wong • N. Engel • J. Kim 8
1 Division of Clinical Epidemiology and Infectious Diseases, Faculty of Medicine, McGill University Health Centre, Montreal, QC, Canada
2 Maastricht University, Maastricht, The Netherlands
3 REACH, Toronto, ON, Canada
4 Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD, USA
5 Canadian AIDS Treatment Information Exchange, Toronto, ON, Canada
6 INSPQ, Montreal, QC, Canada
7 Public Health Agency of Canada, Toronto, ON, Canada
8 National Labs Canada, Winnipeg, MB, Canada

EN